Minimal Clinically Important Difference of Reflux Symptom Score, Reflux Symptom Score‐12, and Reflux Symptom Index
Otolaryngology–Head and Neck Surgery · 18.08.2026
DOI: 10.1002/ohn.70379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 18.08.2026. Verfasst von Jérôme R Lechien. Beteiligte Einrichtung: Department of Surgery, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Koning Boudewijnstichting.
Abstract (Originalsprache)
Objective
To establish the minimal clinically important difference (MCID) of reflux symptom score (RSS), reflux symptom score‐12 (RSS‐12), and Reflux Symptom Index (RSI).
Design
Prospective study.
Setting
University hospital.
Method
Patients with laryngopharyngeal reflux disease (LPRD) at 24‐hour hypopharyngeal‐esophageal impedance pH monitoring were prospectively recruited from the European Reflux Clinic. Pretreatment to posttreatment symptoms and findings were assessed with RSS, RSS‐12, RSI, and reflux sign assessment (RSA). Baseline LPRD severity (mild, moderate, severe) was determined using the RSS‐Quality‐of‐Life (RSS‐QoL). Therapeutic response was defined as improvement by at least one severity category regarding the IFOS classification based on post‐treatment RSS‐QoL. MCID was evaluated using receiver operating characteristic (ROC) curve analysis and Youden‐index.
Results
Evaluation was completed by 351 consecutive patients (208 females), including 127 responders to treatment (36.2%) and 224 (63.8%) partial or nonresponders. RSS‐QoL demonstrated strong correlations with RSS ( ρ = 0.697), RSS‐12 ( ρ = 0.783), and RSI ( ρ = 0.776; all P < .001), validating its use as anchor. Responders showed significantly greater score improvements than non‐responders for all patient‐reported outcome measures ( P < .001). ROC analysis revealed excellent discriminative ability for RSS (AUC = 0.822; 95% CI: 0.78‐0.87), RSS‐12 (AUC = 0.827; 0.78‐0.87), and RSI (AUC = 0.867; 0.76‐0.97). MCID values were 35 points for RSS, (sensitivity 81.1%, specificity 69.6%), 20 points for RSS‐12 (sensitivity 85.3%, specificity 68.2%), and 8 points for RSI (sensitivity 77.3%, specificity 88.6%).
Conclusion
The MCID for improvement in RSS, RSS‐12, and RSI in LPRD patients is a decrease of 35, 20, and 8 points, respectively. This information improves the understanding of therapeutic response, allowing for drug class discontinuation and weaning.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
- Department of Otolaryngology-Head and Neck Surgery, Foch Hospital, Paris Saclay University, Paris, France.
- Department of Otolaryngology-Head and Neck Surgery, Elsan Hospital, Paris, France.
- Department of Otolaryngology-Head and Neck Surgery, CHU Saint-Pierre, Brussels, Belgium.
ORCID-Profile: Jérôme R Lechien
Förderung
- Koning Boudewijnstichting
Zitieren
APA
Lechien, J. R. (2026). Minimal Clinically Important Difference of Reflux Symptom Score, Reflux Symptom Score‐12, and Reflux Symptom Index. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70379
Vancouver
Lechien JR. Minimal Clinically Important Difference of Reflux Symptom Score, Reflux Symptom Score‐12, and Reflux Symptom Index. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70379
BibTeX
@article{Lechien2026,
author = {Lechien, Jérôme R},
title = {Minimal Clinically Important Difference of Reflux Symptom Score, Reflux Symptom Score‐12, and Reflux Symptom Index},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
doi = {10.1002/ohn.70379}
}
EUVIMED